发明名称 TRIARYLCARBOXYLIC ACID DERIVATIVE
摘要 It is intended to provide a remedy or a preventive for hyperuricemia, gout, inflammatory bowel disease, diabetic nephropathy, diabetic retinitis and so on which has a non-nucleic acid structure and exerts an excellent xanthine oxidase inhibitory effect and a uric acid level-lowering effect. It has been confirmed that a novel triarylcarboxlic acid derivative, which is characterized by having a carboxyl-substituted heteroaryl group and an aromatic ring group such as a phenyl group attached in para-position on a benzene ring and further carrying a cyano group on the same benzene ring, has a potent xanthine oxidase inhibitory effect and a uric acid level-lowering effect. Thus, it is found out that this compound is appropriately usable as a remedy or a preventive for hyperuricemia, gout, inflammatory bowel disease, diabetic nephropathy, diabetic retinitis and so on.
申请公布号 KR20080051157(A) 申请公布日期 2008.06.10
申请号 KR20087008055 申请日期 2008.04.03
申请人 ASTELLAS PHARMA INC. 发明人 SATO JUNJI;HATTORI KAZUYUKI;KUBOTA HIROKAZU;MUNAKATA RYOSUKE;ASANO TORU;MAEDA JUNKO;KAWAKAMI MASAKATSU;KAMIKAWA AKIO
分类号 C07D213/79;A61K31/381;A61K31/4025;C07D417/10 主分类号 C07D213/79
代理机构 代理人
主权项
地址